These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2493720)

  • 1. Transplantation in hyperimmunized patients.
    Claas FH; van Rood JJ
    Adv Nephrol Necker Hosp; 1989; 18():317-23. PubMed ID: 2493720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of the frequency of anti-HLA hyperimmunization in patients with kidney transplantation].
    Pongratz G; Goumaz C; Gore SM; Bradley BA; Jeannet M
    Schweiz Med Wochenschr; 1990 Sep; 120(37):1335-8. PubMed ID: 2218455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptable HLA mismatches for highly immunized patients.
    Claas FH; De Meester J; Witvliet MD; Smits JM; Persijn GG; Doxiadis II
    Rev Immunogenet; 1999; 1(3):351-8. PubMed ID: 11256426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S; Valente U; Nocera A
    Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of highly sensitized patients: capitol medical center experience.
    Amante AJ; Ejercito R
    Transplant Proc; 2008 Sep; 40(7):2274-80. PubMed ID: 18790211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperimmunized patients awaiting cadaveric kidney graft: is there a quick desensitization possible?
    Faenza A; Fuga G; Bertelli R; Scolari MP; Buscaroli A; Stefoni S
    Transplant Proc; 2008; 40(6):1833-8. PubMed ID: 18675064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates.
    Duquesnoy RJ; Witvliet M; Doxiadis II; de Fijter H; Claas FH
    Transpl Int; 2004 Jan; 17(1):22-30. PubMed ID: 12955350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
    Bingaman AW; Murphey CL; Palma-Vargas J; Wright F
    Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. IV. An alternative strategy to increase the number of compatible donors for highly sensitized patients.
    Duquesnoy RJ; Howe J; Takemoto S
    Transplantation; 2003 Mar; 75(6):889-97. PubMed ID: 12660520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney transplantation in the United States.
    Cecka JM
    Clin Transpl; 2008; ():1-18. PubMed ID: 19711510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SEOPF high-grade match algorithm: the effect of HLA matching with ROP trays in transplanting highly sensitized patients. Southern Organ Procurement Foundation.
    Tardif GN; McCalmon RT
    Clin Transplant; 1996 Dec; 10(6 Pt 2):594-7. PubMed ID: 8996748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Desensitization protocols in immunized living donor kidney transplant recipients].
    Nocera A
    G Ital Nefrol; 2009; 26(4):499-515. PubMed ID: 19644839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extending options for highly sensitized patients to receive a suitable kidney graft.
    Doxiadis II; Duquesnoy RJ; Claas FH
    Curr Opin Immunol; 2005 Oct; 17(5):536-40. PubMed ID: 16084709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of special programs for kidney transplantation of highly sensitized patients in Eurotransplant.
    Doxiadis II; De Meester J; Smits JM; Witvliet M; de Lange P; Persijn GG; Claas FH
    Clin Transpl; 1998; ():115-20. PubMed ID: 10503090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A special strategy to increase the chance of finding cross-match negative kidneys for highly sensitized patients.
    Claas FH; Gijbels Y; van der Velden-de Munck JJ; de Waal LP; D'Amaro J; Hendriks GF; Persijn GG; van Rood JJ
    Transplant Proc; 1988 Oct; 20(5):947-8. PubMed ID: 3055538
    [No Abstract]   [Full Text] [Related]  

  • 16. Desensitization strategies enabling successful renal transplantation in highly sensitized patients.
    Beimler JH; Susal C; Zeier M
    Clin Transplant; 2006; 20 Suppl 17():7-12. PubMed ID: 17100695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relevance of pretransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients.
    van den Berg-Loonen EM; Billen EV; Voorter CE; van Heurn LW; Claas FH; van Hooff JP; Christiaans MH
    Transplantation; 2008 Apr; 85(8):1086-90. PubMed ID: 18431226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological profile of patients awaiting a renal transplant.
    Díaz I; Sánchez P; Alonso C; Valdés F
    Clin Transplant; 2004 Oct; 18(5):529-35. PubMed ID: 15344955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation.
    Goodman RS; Taylor CJ; O'Rourke CM; Lynch A; Bradley JA; Key T
    Transplantation; 2006 May; 81(9):1331-6. PubMed ID: 16699463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.